• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fatigue (1849); Hair Loss (1877); Memory Loss/Impairment (1958); Pain (1994); Tinnitus (2103); Arthralgia (2355)
Event Date 08/01/2014
Event Type  Injury  
Event Description
This case was initially received via regulatory authority ((b)(6), reference number: (b)(4)) on 19-apr-2019.This spontaneous case was reported by a consumer and describes the occurrence of musculoskeletal pain ("joint and muscular pains") in a (b)(6) female patient who had essure inserted.The occurrence of additional non-serious events is detailed below.On an unknown date, the patient had essure inserted.On (b)(6) 2014, the patient experienced musculoskeletal pain (seriousness criteria medically significant and intervention required), fatigue ("heavy fatigue"), tinnitus ("tinnitus"), amnesia ("memory loss") and alopecia ("hair loss").The patient was treated with surgery.At the time of the report, the musculoskeletal pain, fatigue, tinnitus, amnesia and alopecia outcome was unknown.The reporter provided no causality assessment for alopecia, amnesia, fatigue, musculoskeletal pain and tinnitus with essure.Further company follow-up with the regulatory authority is not possible.No lot number or device sample was received in this case.At this time, we have no information suggesting that the device failed to meet its specifications.We will conduct a review of our complaint records and other non-conformances data; should any new and reportable information become available from our investigation, this will be provided in a supplementary report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k shaw lamberson
100 bayer blvd, p.o. box 915
whippany, NJ 07981
MDR Report Key8541536
MDR Text Key142818689
Report Number2951250-2019-01462
Device Sequence Number1
Product Code HHS
UDI-Device Identifier10888853003051
UDI-Public(01)10888853003051
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign,other
Reporter Occupation Other
Type of Report Initial
Report Date 04/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/23/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS305
Date Manufacturer Received04/19/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age38 YR
-
-